Your browser doesn't support javascript.
loading
[Hormone therapy, fertility and pregnancy in antiphospholipid syndrome]. / Terapias hormonales, fertilidad y embarazo en el síndrome antifosfolipídico.
Fernández-Llanio, N; Alegre-Sancho, J J; Chalmeta-Verdejo, C; Fernández-Carballido, C; Román-Ivorra, J A.
Afiliación
  • Fernández-Llanio N; Sección de Reumatología. Hospital Universitario Dr. Peset. Valencia. España.
Reumatol Clin ; 2(2): 90-106, 2006 Mar.
Article en Es | MEDLINE | ID: mdl-21794309
Antiphospholipid syndrome (APS) carries a risk of thrombosis and infertility. Consequently the use of any type of hormone therapy and pregnancy in APS requires special considerations. The present article provides a broad review of all these issues. The use of contraception, hormone replacement therapy and selective estrogen receptor modulators in APS are described. In vitro fertilization/embryo transfer and ovarian induction in these patients are reviewed. Lastly, the possible fetal and maternal complications that can occur during pregnancy are described and, based on the literature, recommendations for the management of pregnancy in women with APS are provided.

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline Idioma: Es Revista: Reumatol Clin Año: 2006 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline Idioma: Es Revista: Reumatol Clin Año: 2006 Tipo del documento: Article